Final results of a phase II trial of weekly nab-paclitaxel with GM-CSF as chemoimmunotherapy for platinum-resistant epithelial ovarian cancer.

被引：0
|
作者：
Swensen, Ron E.
Goff, Barbara Ann
Childs, Jennifer
Higgins, Doreen
Gooley, Theodore
Fintak, Patricia A.
Buening, Barbara
Disis, Mary L.
机构：
[1] Loma Linda Univ, Loma Linda, CA 92350 USA
[2] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA
[3] Univ Washington, Tumor Vaccine Grp, Seattle, WA 98195 USA
[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[5] Univ Washington, Seattle, WA 98195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5082
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of weekly nab-paclitaxel with GM-CSF as chemoimmunotherapy for platinum-resistant epithelial ovarian cancer.
    Swensen, R. E.
    Childs, J.
    Higgins, D.
    Gooley, T.
    Goff, B. A.
    Fintak, P. A.
    Buening, B.
    Disis, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Phase II trial of weekly nab-paclitaxel with GM-CSF as an immune modulator in recurrent platinum resistant ovarian, fallopian tube, and primary peritoneal cancer: Clinical and immune responses.
    Ben Liao, John
    Swensen, Ron E.
    Reichow, Jessica
    Ovenell, Kelsie J.
    Childs, Jennifer
    Higgins, Doreen
    Buening, Barbara
    Goff, Barbara Ann
    Morishima, Chihiro
    Disis, Mary L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
    Olawaiye, Alexander B.
    Kim, Jae-Weon
    Bagameri, Andrea
    Bishop, Erin
    Chudecka-Glaz, Anita
    Devaux, Alix
    Gladieff, Laurence
    Gordinier, Mary E.
    Korach, Jacob
    McCollum, Michael E.
    Mileshkin, Linda
    Monk, Bradley J.
    Nicum, Shibani
    Nogueira-Rodrigues, Angelica
    Oaknin, Ana
    O'Malley, David M.
    Orlando, Mauro
    Dreiling, Lyndah
    Tudor, Julia C.
    Lorusso, Domenica
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (04)
  • [4] A phase II study of bevacizumab with nab-paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma
    Tillmanns, T. D.
    Lowe, M. P.
    Schwartzberg, L. S.
    Walker, M. S.
    Stepanski, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Phase II trial of dose dense (weekly) paclitaxel with pembrolizumab (MK-3475) in platinum-resistant recurrent ovarian cancer.
    Wenham, Robert Michael
    Apte, Sachin M.
    Shahzad, Mian M.
    Lee, Jae K.
    Dorman, Denise
    Chon, Hye Sook
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer
    Garcia, AA
    O'Meara, A
    Bahador, A
    Facio, G
    Jeffers, S
    Kim, DY
    Roman, L
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 493 - 498
  • [7] Weekly gemcitabine in patients with relapsed platinum-resistant ovarian or peritoneal cancer. Results of phase II study
    Czerniawska, Malgorzata
    Jagiello-Gruszfeld, Agnieszka
    Zbrzezniak, Jolanta
    Wachula, Ewa
    Szablowska-Siwik, Sylwia
    Sikorska, Magdalena
    ANNALS OF ONCOLOGY, 2006, 17 : 172 - 172
  • [8] Final results of a phase II study of voreloxin in women with platinum-resistant ovarian cancer
    Hirte, H. W.
    McGuire, W. P., III
    Edwards, R. P.
    Husain, A.
    Hoskins, P.
    Michels, J. E.
    Matulonis, U.
    Sexton, C.
    Fox, J. A.
    Michelson, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Weekly paclitaxel treatment of patients with progressive platinum resistant epithelial ovarian cancer.
    Le, T
    Baines, KA
    Rambout, L
    Rezaifer, P
    Al Hayki, M
    Hopkins, L
    Fung, MFK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 488S - 488S
  • [10] Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer
    Le, T.
    Hopkins, L.
    Baines, K. A.
    Rambout, L.
    Al Hayki, M.
    Fung, M. Kee Fung
    GYNECOLOGIC ONCOLOGY, 2006, 102 (01) : 49 - 53
12345